91 related articles for article (PubMed ID: 8102569)
1. A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus.
Watson CJ; Gaunt L; Evans G; Patel K; Harris R; Strachan T
Hum Mol Genet; 1993 Jun; 2(6):701-4. PubMed ID: 8102569
[TBL] [Abstract][Full Text] [Related]
2. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
[TBL] [Abstract][Full Text] [Related]
3. Human differentiation-stimulating factor (leukemia inhibitory factor, human interleukin DA) gene maps distal to the Ewing sarcoma breakpoint on 22q.
Budarf M; Emanuel BS; Mohandas T; Goeddel DV; Lowe DG
Cytogenet Cell Genet; 1989; 52(1-2):19-22. PubMed ID: 2558855
[TBL] [Abstract][Full Text] [Related]
4. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
5. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2.
Arai E; Tokino T; Imai T; Inazawa J; Ikeuchi T; Tonomura A; Nakamura Y
Genes Chromosomes Cancer; 1993 Apr; 6(4):235-8. PubMed ID: 7685627
[TBL] [Abstract][Full Text] [Related]
6. Characterization of several DNA polymorphic markers in the LIF gene region.
Moreau-Aubry A; Andre MT; Devilder MC; Resche F; Delattre O; Thomas G; Moisan JP
Hum Genet; 1994 Oct; 94(4):450-1. PubMed ID: 7927349
[TBL] [Abstract][Full Text] [Related]
7. Analysis of chromosome 22 loci in meningioma. Alterations in the leukemia inhibitory factor (LIF) locus.
Pergolizzi RG; Erster SH
Mol Chem Neuropathol; 1994; 21(2-3):189-217. PubMed ID: 7916188
[TBL] [Abstract][Full Text] [Related]
8. The gene for human leukemia inhibitory factor (LIF) maps to 22q12.
Sutherland GR; Baker E; Hyland VJ; Callen DF; Stahl J; Gough NM
Leukemia; 1989 Jan; 3(1):9-13. PubMed ID: 2491897
[TBL] [Abstract][Full Text] [Related]
9. Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers.
Ruttledge MH; Narod SA; Dumanski JP; Parry DM; Eldridge R; Wertelecki W; Parboosingh J; Faucher MC; Lenoir GM; Collins VP
Neurology; 1993 Sep; 43(9):1753-60. PubMed ID: 8414026
[TBL] [Abstract][Full Text] [Related]
10. The mouse neurofibromatosis type 2 gene maps to chromosome 11.
Claudio JO; Malo D; Rouleau GA
Genomics; 1994 May; 21(2):437-9. PubMed ID: 8088840
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis type 2 appears to be a genetically homogeneous disease.
Narod SA; Parry DM; Parboosingh J; Lenoir GM; Ruttledge M; Fischer G; Eldridge R; Martuza RL; Frontali M; Haines J
Am J Hum Genet; 1992 Sep; 51(3):486-96. PubMed ID: 1496982
[TBL] [Abstract][Full Text] [Related]
12. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.
Wolff RK; Frazer KA; Jackler RK; Lanser MJ; Pitts LH; Cox DR
Am J Hum Genet; 1992 Sep; 51(3):478-85. PubMed ID: 1496981
[TBL] [Abstract][Full Text] [Related]
13. Tandem linkage of genes coding for leukemia inhibitory factor (LIF) and oncostatin M (OSM) on human chromosome 22.
Giovannini M; Djabali M; McElligott D; Selleri L; Evans GA
Cytogenet Cell Genet; 1993; 64(3-4):240-4. PubMed ID: 8404048
[TBL] [Abstract][Full Text] [Related]
14. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
15. Genetic characterization of the bovine leukaemia inhibitory factor (LIF) gene: isolation and sequencing, chromosome assignment and microsatellite analysis.
Piedrahita JA; Weaks R; Petrescu A; Shrode TW; Derr JN; Womack JE
Anim Genet; 1997 Feb; 28(1):14-20. PubMed ID: 9124702
[TBL] [Abstract][Full Text] [Related]
16. The genes for oncostatin M (OSM) and leukemia inhibitory factor (LIF) are tightly linked on human chromosome 22.
Rose TM; Lagrou MJ; Fransson I; Werelius B; Delattre O; Thomas G; de Jong PJ; Todaro GJ; Dumanski JP
Genomics; 1993 Jul; 17(1):136-40. PubMed ID: 8406444
[TBL] [Abstract][Full Text] [Related]
17. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH.
Bruder CE; Hirvelä C; Tapia-Paez I; Fransson I; Segraves R; Hamilton G; Zhang XX; Evans DG; Wallace AJ; Baser ME; Zucman-Rossi J; Hergersberg M; Boltshauser E; Papi L; Rouleau GA; Poptodorov G; Jordanova A; Rask-Andersen H; Kluwe L; Mautner V; Sainio M; Hung G; Mathiesen T; Möller C; Pulst SM; Harder H; Heiberg A; Honda M; Niimura M; Sahlén S; Blennow E; Albertson DG; Pinkel D; Dumanski JP
Hum Mol Genet; 2001 Feb; 10(3):271-82. PubMed ID: 11159946
[TBL] [Abstract][Full Text] [Related]
18. A radiation hybrid map of the region on human chromosome 22 containing the neurofibromatosis type 2 locus.
Frazer KA; Boehnke M; Budarf ML; Wolff RK; Emanuel BS; Myers RM; Cox DR
Genomics; 1992 Nov; 14(3):574-84. PubMed ID: 1427886
[TBL] [Abstract][Full Text] [Related]
19. Molecular localization of the t(11;22)(q24;q12) translocation of Ewing sarcoma by chromosomal in situ suppression hybridization.
Selleri L; Hermanson GG; Eubanks JH; Lewis KA; Evans GA
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):887-91. PubMed ID: 1992479
[TBL] [Abstract][Full Text] [Related]
20. Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
Rouleau GA; Seizinger BR; Wertelecki W; Haines JL; Superneau DW; Martuza RL; Gusella JF
Am J Hum Genet; 1990 Feb; 46(2):323-8. PubMed ID: 2105641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
